USD 0.13
(2.84%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | -100.0% |
2021 | 26.49 Million USD | 4.49% |
2020 | 25.35 Million USD | -8.49% |
2019 | 27.7 Million USD | 13.0% |
2018 | 24.51 Million USD | 48840.43% |
2017 | 50.1 Thousand USD | 1791.28% |
2016 | 2649.00 USD | 612.1% |
2015 | 372.00 USD | -95.41% |
2014 | 8096.00 USD | 491.38% |
2013 | 1369.00 USD | -83.48% |
2012 | 8285.00 USD | 168.64% |
2011 | 3084.00 USD | 1.68% |
2010 | 3033.00 USD | -68.01% |
2009 | 9480.00 USD | 2.36% |
2008 | 9261.00 USD | 39.2% |
2007 | 6653.00 USD | 203.79% |
2006 | 2190.00 USD | -85.1% |
2005 | 14.7 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2022 FY | - USD | -100.0% |
2022 Q3 | 26.57 Million USD | 0.19% |
2022 Q2 | 26.52 Million USD | 0.45% |
2022 Q1 | 26.4 Million USD | -0.32% |
2021 FY | 26.49 Million USD | 4.49% |
2021 Q4 | 26.49 Million USD | 1.43% |
2021 Q3 | 26.11 Million USD | -1.2% |
2021 Q2 | 26.43 Million USD | 2.71% |
2021 Q1 | 25.73 Million USD | 1.52% |
2020 FY | 25.35 Million USD | -8.49% |
2020 Q1 | 27.49 Million USD | -0.76% |
2020 Q2 | 28.64 Million USD | 4.19% |
2020 Q4 | 25.35 Million USD | -10.75% |
2020 Q3 | 28.4 Million USD | -0.84% |
2019 Q3 | 39.55 Million USD | -6.05% |
2019 Q4 | 27.7 Million USD | -29.95% |
2019 Q1 | 39.96 Million USD | 42.77% |
2019 FY | 27.7 Million USD | 13.0% |
2019 Q2 | 42.1 Million USD | 5.34% |
2018 Q1 | 102.66 Thousand USD | 104.93% |
2018 FY | 24.51 Million USD | 48840.43% |
2018 Q4 | 27.99 Million USD | 1388.42% |
2018 Q3 | 1.88 Million USD | 249.96% |
2018 Q2 | 537.45 Thousand USD | 423.49% |
2017 Q4 | 50.1 Thousand USD | 4413.51% |
2017 Q2 | 596.00 USD | -63.7% |
2017 Q1 | 1642.00 USD | -38.01% |
2017 FY | 50.1 Thousand USD | 1791.28% |
2017 Q3 | 1110.00 USD | 86.24% |
2016 FY | 2649.00 USD | 612.1% |
2016 Q4 | 2649.00 USD | -36.23% |
2016 Q3 | 4154.00 USD | 428.5% |
2016 Q2 | 786.00 USD | -64.78% |
2016 Q1 | 2232.00 USD | 500.0% |
2015 Q1 | 17.51 Thousand USD | 116.3% |
2015 Q3 | 1280.00 USD | -86.0% |
2015 Q4 | 372.00 USD | -70.94% |
2015 FY | 372.00 USD | -95.41% |
2015 Q2 | 9144.00 USD | -47.78% |
2014 Q1 | 7486.00 USD | 446.82% |
2014 Q2 | 818.00 USD | -89.07% |
2014 Q4 | 8096.00 USD | 52.21% |
2014 Q3 | 5319.00 USD | 550.24% |
2014 FY | 8096.00 USD | 491.38% |
2013 Q2 | 3132.00 USD | -66.8% |
2013 Q3 | 1055.00 USD | -66.32% |
2013 FY | 1369.00 USD | -83.48% |
2013 Q1 | 9435.00 USD | 13.88% |
2013 Q4 | 1369.00 USD | 29.76% |
2012 Q1 | 708.00 USD | -77.04% |
2012 FY | 8285.00 USD | 168.64% |
2012 Q4 | 8285.00 USD | 123.2% |
2012 Q3 | 3712.00 USD | 2358.28% |
2012 Q2 | 151.00 USD | -78.67% |
2011 Q4 | 3084.00 USD | -1.19% |
2011 Q2 | 745.00 USD | 893.33% |
2011 Q1 | 75.00 USD | -97.53% |
2011 Q3 | 3121.00 USD | 318.93% |
2011 FY | 3084.00 USD | 1.68% |
2010 Q4 | 3033.00 USD | 124.83% |
2010 Q3 | 1349.00 USD | -50.96% |
2010 Q2 | 2751.00 USD | -27.49% |
2010 Q1 | 3794.00 USD | -59.98% |
2010 FY | 3033.00 USD | -68.01% |
2009 Q4 | 9480.00 USD | 14.95% |
2009 Q1 | 20.47 Thousand USD | 121.13% |
2009 Q3 | 8247.00 USD | -54.92% |
2009 FY | 9480.00 USD | 2.36% |
2009 Q2 | 18.29 Thousand USD | -10.66% |
2008 Q1 | 3758.00 USD | -43.51% |
2008 Q3 | 9165.00 USD | -48.86% |
2008 FY | 9261.00 USD | 39.2% |
2008 Q4 | 9261.00 USD | 1.05% |
2008 Q2 | 17.92 Thousand USD | 376.93% |
2007 Q1 | 2131.00 USD | -2.69% |
2007 Q2 | 4459.00 USD | 109.24% |
2007 Q3 | 153.00 USD | -96.57% |
2007 Q4 | 6653.00 USD | 4248.37% |
2007 FY | 6653.00 USD | 203.79% |
2006 FY | 2190.00 USD | -85.1% |
2006 Q4 | 2190.00 USD | 0.0% |
2005 FY | 14.7 Thousand USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
The Amacore Group, Inc. | 12.04 Million USD | 100.0% |
Arem Pacific Corporation | 259.81 Thousand USD | 100.0% |
Assisted 4 Living, Inc. | 264.81 Thousand USD | 100.0% |
BioCorRx Inc. | 388.88 Thousand USD | 100.0% |
Bionik Laboratories Corp. | 3.36 Million USD | 100.0% |
Banyan Corp. | 4.5 Million USD | 100.0% |
Clearday, Inc. | 33.75 Million USD | 100.0% |
Dental Patient Care America, Inc. | 2.24 Million USD | 100.0% |
Quantum Medical Transport, Inc. | 1298.56 USD | 100.0% |
Empower Clinics Inc. | 2.96 Million USD | 100.0% |
First Choice Healthcare Solutions, Inc. | 3.12 Million USD | 100.0% |
Selectis Health, Inc. | 40.67 Million USD | 100.0% |
Ethema Health Corporation | 11.51 Million USD | 100.0% |
HealthLynked Corp. | 4.28 Million USD | 100.0% |
Healthcare Solutions Management Group, Inc. | 93.12 Million USD | 100.0% |
JRSIS Health Care Corporation | 2.14 Million USD | 100.0% |
Comjoyful International Company | 1.21 Million USD | 100.0% |
Medical Facilities Corporation | 353.06 Million USD | 100.0% |
MedSmart Group Inc. | 751.69 Thousand USD | 100.0% |
North America Frac Sand, Inc. | 356.16 Thousand USD | 100.0% |
Nova Leap Health Corp. | 20.89 Million USD | 100.0% |
Nexteligent Holdings, Inc. | 446.95 Thousand USD | 100.0% |
PAO Group, Inc. | 575.00 USD | 100.0% |
Primemd Inc. | 15.32 Million USD | 100.0% |
Raffles Medical Group Ltd | 1.15 Billion USD | 100.0% |
Ryman Healthcare Limited | 7.82 Billion USD | 100.0% |
Stem Cell Authority, Ltd. | 15.00 USD | 100.0% |
SETO Holdings, Inc. | - USD | NaN% |
Optima Medical Innovations Corp. | 7.22 Million USD | 100.0% |
Mycotopia Therapies, Inc. | 2.21 Million USD | 100.0% |
U.S. NeuroSurgical Holdings, Inc. | 1.32 Million USD | 100.0% |
Veltex Corporation | 1.8 Million USD | 100.0% |
World Financial Holding Group | 292.00 USD | 100.0% |
Xcelerate Inc. | 1.91 Million USD | 100.0% |